Cervical cancer patients with a low expression of ITM2A were more likely have adenocarcinoma or adenosquamous carcinoma, while cervical cancer patients with a high expression of ITM2A tended have squamous carcinoma. The gene discussed is ITM2A; the disease is adenosquamous carcinoma.